|
ADHD News Articles
from the adhd information library
Greetings!
Here is your weekly edition of your ADHD News Articles from the ADHD Information Library at http://newideas.net. Visit us for the latest news and insights on parenting and teaching those with ADHD.
|
Concerta Approved for Adult ADHD
The FDA was busy last week as it approved two drugs for use in adult
disorders. The FDA approved the drug Concerta for use in adult ADHD,
and approved the first generic versions of Risperdal (risperidone)
tablets to treat schizophrenia, bipolar disorder, and other psychiatric
conditions. Here we will focus on the approval of Concerta for adults
with ADHD.
Concerta is a CNS stimulant medication is used to treat Attention
Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and
older, adolescents, and now adults up to the age of 65. It is thought
that stimulants work by helping to increase dopamine and
norepinephrine, and perhaps blood flow, in the brain.
Concerta is a timed-release form of methylphenidate (Ritalin is made
from methylphenidate). This is why people like it. Instead of having to
take two or three doses of Ritalin each day, with the Ritalin "ups" and
"downs" through the day, they can get roughly the same benefits all day
long from one Concerta dose in the morning. Concerta has a half-life of
3.5 hours, which is about twice as long as Ritalin.
It is recommended that children and teenagers begin Concerta with just
a small dose (18 mg/day), but the FDA is permitting adults to start
with either 18 mg/day or 36 mg/day. We are not medical doctors, so we
don't want to say anything more on this than that you should always
start with a small dose and see how you do before jumping to a bigger
dose of a medication for ADHD. We'd say this for any stimulant, but
especially a methylphenidate product.
| |
Adderall XR, Shire Pharmaceuticals, and a Glimpse Into the Future
Barron's Magazine, is a financial weekly published by Dow Jones that
keeps a very close eye on the world's financial news and the
corporations that are making news. Recently they ran a short series of
articles on Shire Pharmaceuticals and the potential problems ahead for
the company.
The reason that these articles are of interest to parents of children
with ADHD, is that Shire makes Adderall, Adderall XR, and Vyvanse, all
major medications used for ADHD treatment. The problems for Shire may
be blessings for parents, so here are some of the details:
Shire has the patent on Adderall XR, which has been a controversial
medication in the treatment of ADHD for several years now. And Shire's
patent on the drug expires in April of 2009. This means that other
companies can begin selling "generic" versions of Adderall XR (which
will initially be manufactured by Shire) next spring, potentially at
prices far lower than Shire's prices for Adderall XR.
Barron's claims that Shire's Adderall XR is the most prescribed drug
for ADHD in the world with about 23% of the market, and that of Shire's
$2.4 billion in revenue last year, over 40% came from Adderall sales
(about $1 billion). As investors look into the near future, and respond
to what they see, Shire Pharmaceutical's stock has fallen over 40%
since September of 2007.
Vyvanse is Shire's newest ADHD medication, a true pro-drug, where the
medication's precursors are linked to amino acids to make the
medications less likely to be abused. At present Barron's reports that
Vyvanse has captured about 7.5% of the ADHD drug market, and that it is
not gaining in popularity as quickly as some had hoped.
Continue reading this article...
This full article can be found at: http://newideas.net/adhd/medication/adderall-patent
|
Mercury Poisoning, Heavy Metal or Chemical Toxicity, and Brain Development
Protect Your Child's Brain from Mercury and Other Heavy Metals and Environmental Chemicals
The
dangers of lead poisoning and mercury toxicity have been known for
centuries. And research over the past thirty years has shown that
low-level exposures to heavy metals from paint, exhaust, and other
environmental sources has toxic effects. These metals are neurotoxins
and adversely impact brain development and performance.
Mercury
exposure has been linked to lower intelligence scores and
neurobehavioral problems in children of mothers exposed to contaminated
seafood. We are convinced that dental amalgam fillings, which are over
40% mercury, plus toxic nickel, copper, and cadmium, also can cause
neurological and immune system dysfunctions.
Two informative but
shocking videos on the internet illustrate the points. The first video
from the International Academy of Oral Medicine and Toxicity shows that
amalgam fillings expose their "owners" to mercury vapor. The second video from the University of Calgary, Ontario, Canada, shows mercury ions destroying nerve cells. These are "must see" videos.
One
in six children in the USA has a developmental disability or
neuro-developmental disorder, such as ADHD, autism or Asperger's, PDD,
etc. It is possible, in fact likely, that exposure to heavy metals and
chemical toxins both in utero and in early childhood cause damage to
the developing brain, resulting in various neurological disorders.
Continue reading this article...
This full article can be found at: http://newideas.net/adhd/differential-diagnosis/mercury-chemical-toxicity
|
|
|
|
|
Try Attend!
ATTEND Clinical Trial Results
View the clinical trials results. See
why there are so many happy customers...(more)
Compare ATTEND to RITALIN and other stimulants used to reat ADHD
In "head to head" competition:
Ritalin
vs ATTEND...(see who wins) 
72 ingredients in Attend
The ATTEND formula was carefully
developed by a
neuro-scientist, tested for effectiveness, and is
available today! Learn more about ATTEND here.
|
|
